T. Rowe Price Associates’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $14K | Hold |
|
|||||
|
2022
Q2 | $21K | Hold |
|
|||||
|
2022
Q1 | $37K | Hold |
|
|||||
|
2021
Q4 | $52K | Hold |
|
|||||
|
2021
Q3 | $77K | Sell |
|
|||||
|
2021
Q2 | $125K | Sell |
|
|||||
|
2021
Q1 | $142K | Hold |
|
|||||
|
2020
Q4 | $101K | Sell |
|
|||||
|
2020
Q3 | $427K | Hold |
|
|||||
|
2020
Q2 | $435K | Buy |
|
|||||
|
2020
Q1 | $425K | Buy |
|
|||||
|
2019
Q4 | $421K | Buy |
|
|||||
|
2019
Q3 | $143K | Sell |
|
|||||
|
2019
Q2 | $545K | Sell |
|
|||||
|
2019
Q1 | $605K | Buy |
|
|||||
|
2018
Q4 | $122K | Sell |
|
|||||
|
2018
Q3 | $584K | Buy |
|
|||||
|
2018
Q2 | $567K | Buy |
|
|||||
|
2018
Q1 | $362K | Buy |
|
|||||
|
2017
Q4 | $521K | Buy |
|